Enhanced Clostridioides difficile Infection Prevention With a Pharmacy-Controlled Policy That Adds a 3-Strain Lactobacillus Probiotic Concomitantly to Antibiotic Therapy.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 33966076.
- Also identified by DOI 10.1093/cid/ciab414 and PMC identifier 8528394.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
When 70% of antibiotic users took a 3-strain Lactobacillus probiotic preparation the hospital-wide rate of healthcare-associated Clostridioides difficile infection improved significantly. The incidence of C. difficile infection for those taking the probiotic along with multiple antibiotics or a single high-risk antibiotic was decreased by at least half.
Medical subject headings
- Clostridioides difficile
- Clostridium Infections
- Pharmacy
- Probiotics